Background
==========

Until recently, the use of MRI in patients with PPM\'s was prohibited. The lifetime probability of a patient with a cardiac device requiring an MRI is 50-75%. Serious adverse events occurring during MRI of patients with cardiac devices are rare, but include asystole, VF and death. There is a clinical need to develop knowledge of MR safe devices and safe scanning protocols.

This study specifically address these issues in the SJM Accent MR PPM System, undergoing a dedicated CMR scan at 1.5 T, with a long scan duration at max power.

Methods
=======

Patients were recruited into the MAPS trial and implanted with a SJM Accent ppm and 2 tendril MR leads. All patients were PPM dependent. CMR was performed more than 6 weeks following implant. Pacing capture thresholds, impedances and battery voltages were assessed prior to, between and immediately following the CMR scan. The scans were performed on a Siemens Avanto 1.5T scanner. All patients were placed in an MR pacing mode. Each scan duration was over 90 mins.

Results
=======

Between February 2012 and February 2014, 50 patients were implanted with the SJM MR ppm. The mean age of the patients was 67.3±8.1 years, 30 male. All 50 patients had at least 1 CMR.

There were no significant adverse events reported during any of the scans and no loss of capture was seen in any scan.

Pacing thresholds
-----------------

The mean pacing threshold for RVOT lead at implant was 0.67±0.22V and at 2 week check was 0.73±0.21V. Pacing thresholds prior to the 1^st^ CMR scan, between the lead switch over and following the scan were 0.66±0.16V, 0.66±0.16V and 0.69±0.27V respectively, p=0.34.

The mean pacing threshold for the apical lead at implant was 0.71±0.29V and at 2 week check was 0.74±0.26V. Pacing thresholds prior to the 1^st^ CMR scan, between the lead switch over and following the scan were 0.69±0.17V, 0.69±0.16V and 0.69±0.16V respectively, p= 1.

Impedance
---------

The mean pacing impedance for the RVOT lead at implant was 739±168Ω and at 2 week check was 655±251Ω. Pacing impedances prior to the CMR scan, between the lead switch over and following the scan were 601±123Ω, 595±114Ω and 579±141Ω respectively, p=0.008.

The mean pacing impedance for Apical lead at implant was 631±130Ω and at 2 week check was 616±81Ω. Pacing impedances prior to the CMR scan, between the lead switch over and following the scan were 612±81Ω, 611±80Ω and 574±69Ω respectively, p=0.004.

Battery
-------

The mean battery voltage prior to, between and following every CMR scan did not alter acutely. CMR scan 1 was at 2.99±0.03V.

Specific absorption rate

The max SAR of 4 w/kg was never exceeded. See Fig [1](#F1){ref-type="fig"}.
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Tendril leads 5 control patients had the MR system but no CMR scans. Table [1](#T1){ref-type="table"} compares the parameters between cohorts over 12 months. A similar trend in parameter changes was observed between the CMR and non-CMR pacing cohort.

###### 

Control group of 5 patients with MR system but no CMR scans compared to study group.

                              0 months        2 months   12 months
  --------------- ----------- --------------- ---------- -----------
  Threshold (V)   Control     0.625 +/-0.14   0.6±04     0.65±0.3
                                                         
                  CMR group   0.67±0.16       0.67±0.2   0.7±0.48
                                                         
  Impedance Ω     Control     698±135         568±85     537±92
                                                         
                  CMR group   739±167         585±108    558±154
                                                         
  Battery (V)     Control     2.99            2.99       2.96
                                                         
                  CMR group   3               3          2.96

Conclusions
===========

Prolonged max power CMR scanning of the St Jude Accent - Tendril IPG system at 1.5 T is safe and has no clinically relevant effects on PCT, voltage and Battery power.
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